147782-19-2
基本信息
2-(2,3-dicarboxycyclopropyl)glycine
(2S,2'R,3'R)-2-(2',3'-DICARBOXYCYCLOPROPYL)GLYCINE
1,2-Cyclopropanedicarboxylic acid, 3-[(S)-aminocarboxymethyl]-, (1R,2R)-
物理化学性质
沸点 | 503.9±40.0 °C(Predicted) |
密度 | 1.819±0.06 g/cm3(Predicted) |
储存条件 | Desiccate at RT |
溶解度 | 可微溶于水 |
酸度系数(pKa) | 2.40±0.10(Predicted) |
形态 | 粉末 |
颜色 | White to off-white |
水溶解性 | 溶于水至100mM |
安全数据
危险性符号(GHS) | GHS07 |
警示词 | 警告 |
危险性描述 | H319-H302 |
防范说明 | P264-P280-P305+P351+P338-P337+P313P-P264-P270-P301+P312-P330-P501 |
常见问题列表
mGluR2R 0.35 μM (EC 50 ) |
mGluR3R 0.09 μM (EC 50 ) |
mGluR1R 389 μM (IC 50 ) |
mGluR5 630 μM (IC 50 ) |
mGluR4R 22.5 μM (IC 50 ) |
mGluR6 39.6 μM (IC 50 ) |
mGluR7 40.1 μM (IC 50 ) |
mGluR8 32 μM (IC 50 ) |
DCG-IV is also an NMDA receptor agonist in the rat cortical slice.
DCG-IV (1-10 mg/kg; i.p.) depresses the phencyclidine (PCP)-induced hyperlocomotion.
Animal Model: | Male ICR mice weighing about 40 g (PCP-induced locomotor activity) |
Dosage: | 10, 5, or 1 mg/kg |
Administration: | I.p. |
Result: | Reduced spontaneous activities of the animals at 10 or 5 mg/kg. |